Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
Purpose
This study evaluates the use of extended venous thromboembolism prophylaxis (ePPx) following abdominopelvic cancer surgery within the NCI Community Oncology Research Program (NCORP) network, targeting surgeons and surgical advanced practice providers (APPs).
Conditions
- Malignant Digestive System Neoplasm
- Malignant Female Reproductive System Neoplasm
- Malignant Genitourinary System Neoplasm
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
SURGEON ELIGIBILITY CRITERIA FOR OPEN STEP 0 ENROLLMENT: * Any surgeon performing gastrointestinal, genitourinary, or gynecologic cancer surgery within an NCORP site, including general surgeons, surgical specialists, urologists, and gynecologists. Surgeons do not need to be involved in research or have a Cancer Therapy Evaluation Program Identification (CTEP ID) to participate in this study SURGICAL APP ELIGIBILITY CRITERIA FOR OPEN STEP 0 ENROLLMENT: * APPs providing postoperative care to patients operated by surgeons performing gastrointestinal, genitourinary, or gynecologic cancer surgery within an NCORP site, including general surgeons, surgical specialists, urologists, and gynecologists. Surgical APPs do not need to be involved in research or have a CTEP ID to participate in this study SURGEON ELIGIBILITY CRITERIA FOR OPEN STEP 1 ENROLLMENT: * Must have completed the STOP-VTE Survey - Surgeon electronically (preferred) or on paper and have it transferred to Research Electronic Data Capture (REDCap) by the contact person(s) SURGICAL APP ELIGIBILITY CRITERIA FOR OPEN STEP 1 ENROLLMENT: * Must have completed the STOP-VTE Survey - APP electronically (preferred) or on paper and have it transferred to REDCap by the contact person(s) SITE ELIGIBILITY PART 1-SITE ENROLLMENT IN OPEN: * Have at least one eligible surgeon or surgical APP who completed the STOP-VTE Survey - Surgeon/APP
Exclusion Criteria
- N/A
Study Design
- Phase
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
| Observational Part 1 | Surgeons and APPs complete a survey on study. After completion of surgeon or APP survey, site contact person or CCDR lead complete site surveys on study. |
|
| Observational Part 2 | Subset of surgeons and APPs from Part 1 complete a semi-structured interview on study. |
|
| Observational Part 3 | Site contact person or CCDR lead complete a survey to identify a EHR Report Specialist on study. EHR Report Specialist performs an EHR Data Extraction and provides feedback on the process in a survey. |
|
Recruiting Locations
Fort Smith, Arkansas 72903
800-378-9373
Newark, Delaware 19713
Newark, Delaware 19713
Newark, Delaware 19718
Lawrenceville, Georgia 30046
Cedar Rapids, Iowa 52403
319-365-4673
Cedar Rapids, Iowa 52403
319-363-2690
Des Moines, Iowa 50309
Des Moines, Iowa 50314
Des Moines, Iowa 50316
515-241-8704
Scarborough, Maine 04074
Elkton, Maryland 02192
Ann Arbor, Michigan 48106
Chelsea, Michigan 48118
Livonia, Michigan 48154
Bemidji, Minnesota 56601
Brainerd, Minnesota 56401
Duluth, Minnesota 55805
Branson, Missouri 65616
417-269-4520
Kansas City, Missouri 64116
913-588-3671
Liberty, Missouri 64068
913-588-1569
Springfield, Missouri 65804
417-269-4520
Springfield, Missouri 65807
417-269-4520
Pinehurst, North Carolina 28374
Winston-Salem, North Carolina 27157
Dayton, Ohio 45428
Oklahoma City, Oklahoma 73120
405-752-3402
Charleston, South Carolina 29406
Greenville, South Carolina 29605
Chippewa Falls, Wisconsin 54729
Wausau, Wisconsin 54401
877-405-6866
More Details
- Status
- Recruiting
- Sponsor
- Wake Forest University Health Sciences
Detailed Description
PRIMARY OBJECTIVE: I. To evaluate self-reported utilization of guideline concordant extended venous thromboembolism (VTE) prophylaxis (ePPx) following abdominopelvic cancer surgery within a sample of surgeons practicing within NCORP based on the Part 1 surgeon survey. SECONDARY OBJECTIVES: I. Evaluate site factors (e.g., proportion of publicly insured patients, proportion of Black patients, presence of a medical school, NCI designation) and surgeon factors (e.g., fellowship training, years in practice) associated with surgeon self-reported guideline concordant ePPx utilization (Part 1). II. Conduct semi-structured interviews among a subset of surgeons and surgical APPs to assess: 1) Barriers/facilitators toward ePPx after cancer surgery and 2) Acceptability of clinical decision support tools to support VTE prophylaxis prescribing (Part 2). III. Extract EHR data from select practices to assess the feasibility of query-based electronic health record (EHR) data extraction for identification of (i) patients undergoing cancer surgery, and (ii) prescription of guideline concordant ePPx among eligible patients (Part 3). OUTLINE: This is an observational study. PART 1: Surgeons and APPs complete a survey on study. After completion of surgeon or APP survey, site contact person or Cancer Care Delivery Research (CCDR) lead complete site surveys on study. PART 2: A subset of surgeons and APPs from part 1 complete a semi-structured interview on study. PART 3: Site contact person or CCDR lead complete a survey to identify a EHR Report Specialist on study. EHR Report Specialist performs an EHR Data Extraction and provides feedback on the process in a survey.